BRIA Capital Group’s Merck MRK Stock Holding History

BRIA Capital Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$868K	Buy	5,973 +1,110	+23%	+$153K	0.59%	47
2026 Q2	$625K	Buy	+4,863	New	+$569K	0.46%	49

Other funds holding MRK

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

BRIA Capital Group's MRK Position: Q3 2026 in Review

BRIA Capital Group increased its Merck (MRK) stake by 23% in Q3 2026, buying an estimated $153K and bringing the position to 5,973 shares worth $868K. The position accounts for 0.59% of the portfolio, ranked #47.

BRIA Capital Group first reported a position in MRK in Q2 2026 and has held it in 2 quarters since. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

BRIA Capital Group held 5,973 shares of Merck worth $868K as of Q3 2026.
BRIA Capital Group bought 1,110 Merck shares in Q3 2026, an estimated $153K.
Merck made up 0.59% of BRIA Capital Group's portfolio in Q3 2026, its #47 holding.
BRIA Capital Group first reported a position in Merck in Q2 2026 and has held it in 2 quarters since.
3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on BRIA Capital Group's 13F filing for Q3 2026, filed 22 Oct 2026.